Menu
Montecito
Pac Premier
Giving Guide
Loading...
You are here:  Home  >  'Amgen'  -  Page 55
Latest

California M&A surge could reach Tri-Counties’ corporate world

By   /  Friday, June 6th, 2014  /  Columns, Opinion, Tri-County Economy  /  Comments Off on California M&A surge could reach Tri-Counties’ corporate world

Henry Dubroff

There are signs that the takeover wave that’s engulfed many sectors, notably pharmaceuticals and high-tech, may soon wash up on the beaches of the Tri-Counties.

Read More →
Latest

Amgen to cut 70 jobs

By   /  Thursday, June 5th, 2014  /  Central Coast Health Watch, East Ventura County, Latest news, Technology, Top Stories, Tri-County Economy, Tri-County Public Companies  /  2 Comments

Thousand Oaks-based Amgen plans to lay off 70 people, primarily in its information systems department at its headquarters.

Read More →
Latest

Pharma shakeups put pressure on top brass at Amgen to perform

By   /  Friday, April 25th, 2014  /  Columns, Opinion  /  Comments Off on Pharma shakeups put pressure on top brass at Amgen to perform

Henry Dubroff

With activist investor Bill Ackman pushing to buy Botox maker Allegran in a bid with upstart Valeant and restructurings under way at pharma giants GlaxoSmithKline, Eli Lilly & Co. and Novartis, it’s logical to question whether biotech giant Amgen will be next. So far the answer seems to be “not yet” — with one big Read More →

Read More →
Latest

Amgen shares slide on lackluster Q1 profits

By   /  Tuesday, April 22nd, 2014  /  Banking & Finance, Banking Industry, Top Stories, Tri-County Public Companies  /  Comments Off on Amgen shares slide on lackluster Q1 profits

Shares of Amgen fell nearly 3 percent in late trading on Tuesday following a weaker-than-expected first quarter earnings report from the world’s biggest biotech company.

Read More →
Latest

Amgen pays $290M to exit osteoporosis drug deal

By   /  Thursday, April 3rd, 2014  /  Banking & Finance, Banking Industry, Technology, Top Stories, Tri-County Public Companies  /  Comments Off on Amgen pays $290M to exit osteoporosis drug deal

Amgen will pay $290 million to end its collaboration with British drugmaker GlaxoSmithKline to commercialize the osteoporosis drug denosumab in certain markets outside the U.S.

Read More →
Latest

Baxter BioScience to be spun out

By   /  Thursday, March 27th, 2014  /  East Ventura County, Technology, Top Stories, Tri-County Economy  /  Comments Off on Baxter BioScience to be spun out

Baxter International, an Illinois company that is a major employer in the Conejo Valley, is planning to split itself into two companies.

Read More →
Latest

Amgen to cut 252 jobs

By   /  Thursday, March 6th, 2014  /  Top Stories, Tri-County Public Companies  /  Comments Off on Amgen to cut 252 jobs

Thousand Oaks-based Amgen plans to lay off 252 employees in Thousand Oaks by the end of April, bringing the total jobs cut since 2007 from Ventura County’s largest private-sector employer to about 1,150.

Read More →